Gander-Meisterernst

Gander-Meisterernst

Regulatory Strategies offers consulting and services in the area of regulatory affairs for medicinal products/drugs, including small molecules and biotech products, from early development, when entering into first in human trials - to registration. Our main focus are global regulatory strategies and scientific advice procedures, European clinical trial and marketing authorization applications, EU and US orphan drug applications, as well as regulatory due diligence processes.
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /